Syneos Health has announced the acquisition of RxDataScience, a healthcare-focused data analytics, data management and artificial intelligence company.
RxDataScience’s product lifecycle solutions include scientific computing for R&D, patient journey, decentralized trials, RWE, predictive analytics and commercial market research. Additionally, RxDataScience offers a consulting-based model providing an iterative approach to develop and deliver analytics solution prototypes in six-to-eight-week sprints.
RxDataScience further scales Syneos Health’s data science abilities, adding capabilities and knowledge in data engineering and management. RxDataScience will be part of the Syneos Health Dynamic Assembly network.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.